Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (9241)	6/5/1998 4:51:00 PM
From: RealMuLan	Read Replies (1) \| Respond to of 23519

This is from Yahoo: Message 9536 of 9557 A friend on the inside ToyTrainer Jun 5 1998 3:21PM EDT To all you longs: I thought you might be interested to know that I spoke to friend that works for VVUS. This person stated that despite the recent stocks performance, employee morale is super high. Reason being, leland's message on Monday will be both strong and positive. In addition, new plant is running very strong due to European demand. Sales concentration while still focused domestically has shifted aggressively to an international level. Hey shorty! You better cover my man! PS: I have been reading this board for 60 days and never in my life seen so many morons! God bless America! GO VIVUS!!!!!!!!!!!

To: DaiS who wrote (9241)	6/5/1998 5:22:00 PM
From: Tunica Albuginea	Read Replies (1) \| Respond to of 23519

DaiS remarkable hoe the media put faith in abstracts which are simply barnyard food material, dished over, unedited, non-peer reviewed, published anywhere in a non-tight content-aerea like the AUA meeting where you can pretty much get up there and say what you want. For other comments, i have been posting in the SI PFE thread, yesterday and today, TA

To: DaiS who wrote (9241)	6/5/1998 5:45:00 PM
From: Frostman	Read Replies (3) \| Respond to of 23519

DiaS, Great post on the Fulgham study! I wonder what the results would have been had they challenged the entire population to 1000ug Muse as the initial intervention? Also, in step 3, I am lost to understand why they elected to not test the remaining 60 subjects in the 500ug failure condition (52% of the total population) to 1000ug Muse. Your 48% figure clearly defines their probable results. At some point, I would be interested in seeing what you would design as a fair head-to-head test between the four or five ED drugs. Frostman